We report two interesting cases of SMECE with concurrent papillary thyroid carcinoma (PTC), both harboring the B-Raf proto-oncogene, serine/threonine kinase (BRAF) V600E activating mutation in the SMECE tumor. Here, BRAF is linked to thyroid gland papillary carcinoma.